Aclaris Therapeutics (ACRS)'s 30-day implied volatility (IV30) was 80.2% at the close on November 4, 2026, down from 84.9% the day before, against a 52-week range of 49.6% to 154.0%. Its 20-day historical volatility was 90.5%.
Data as of November 4, 2026.